Important Notice Regarding Oxervate

Posted in Latest News on January 24, 2020.

During the January 17, 2020 Board of Optometry meeting, the Board approved Oxervate (Cenergermin-bkbj) 0.002% for addition to Rule 64B13-18.002, Florida Administrative Code – Formulary of Topical Pharmaceutical Agents.

Important Note: At this time, Oxervate cannot be prescribed by Certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and both may be prescribed by Certified Optometrists at that time.



More Latest News

Important Information on Fraudulent Emails to Practitioners
August 1, 2023

The Department of Health, Division of Medical Quality Assurance, is warning Florida health care practitioners about fraudulent emails that have been received by multiple licensees. Continue reading


New Legislation Impacting Your Profession
June 28, 2023

Click here to view a full list of bill summaries from the 2023 Florida Legislative Session that may impact your profession. Continue reading